All Stories
Heavy-duty packaging demand surges amid e-commerce boom
Valued at USD 60.5 billion in 2024, the heavy-duty corrugated packaging market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.57% from 2026 to 2035, according to Towards Packaging .
Targeted Green Investments Surge Amid Broader ESG Retreat
Investors pulled $21 billion from US sustainable funds last year, even as broader US mutual funds and ETFs attracted a substantial $760 billion in 2025, according to The Daily Upside .
Major investments fuel AI digital health startup innovation
In 2024, HealthTech investments in Latin America surged, marking a global acceleration in AI-driven healthcare funding for innovative startups.
Enterprise AI adoption strategies: Growth vs. valuation in 2026
In early 2026, Microsoft dramatically increased its capital expenditures to $37.
European Venture Capital Surges With Double-Digit Growth in 2024
In 2024, European venture capital fundraising surged by 43%.
Pipe raises $16M equity; debt fuels financing growth
Pipe, a revenue-based financing platform, has quietly secured $16 million in a new funding round.
OpenAI's Enterprise Revenue Surges Past 40% With Agentic Workflows
OpenAI's enterprise business now accounts for over 40% of its total revenue, a dramatic shift driven by the rapid integration of AI agents into core business operations.
Geopolitical tensions, energy shocks weaken MENA, Asia economic outlook
The current blockade of the Strait of Hormuz is creating an oil and gas crisis more severe than the combined crises of 1973, 1979, and 2022, according to The Guardian .
Anthropic, OpenAI Intensify Enterprise Market Focus with New AI Tools
AI developers Anthropic and OpenAI are intensifying their enterprise market focus, launching new tools and pricing models to attract large business customers. This strategic shift is reshaping corporate AI integration and driving a sector-wide repricing event in enterprise software.
The AI ROI Paradox: Unpacking Enterprise Asset Management Adoption Insights
Despite massive investments in enterprise generative AI, many organizations struggle to achieve substantial ROI. This article unpacks the disconnect between expenditure and outcome, offering insights into successful AI adoption in EAM.
The Practical AI Shift: Analyzing Successful Use Cases Across Enterprise Sectors
Enterprise AI adoption has moved beyond hype. This analysis explores the successful use cases and data-driven integration patterns emerging in key enterprise sectors like manufacturing and customer experience.
Beyond the Hype: Data Reveals the Reality of Enterprise AI Adoption
While many companies report using AI, data shows a complex reality: widespread experimentation often precedes deep, strategic integration. This article delves into where enterprises are truly adopting AI, current spending trends, and future projections.
Cloudflare Targets Enterprise Market With Platform Consolidation and Security Updates
Cloudflare is targeting the enterprise market with a new platform consolidation strategy, introducing centralized account management and enhanced security features. These updates aim to simplify network management and bolster security for corporate clients.
DayOne Accelerator Program Offers Equity-Free Model for Healthtech Startups
The DayOne Accelerator Program is now accepting applications from healthtech startups for its three-month, equity-free program in Basel, Switzerland. It targets early-stage global companies in healthtech and techbio, focusing on pharmaceutical R&D.
How Industrial Decarbonization Forges Growth in Power Tools and Cryogenic Air Separation Markets
The global push for industrial decarbonization is creating parallel growth trajectories in two seemingly disconnected sectors: the advanced technology of cryogenic air separation units and the foundational utility of global power tools.
DayOne Accelerator Program for Healthtech Startups Launches Applications
The DayOne Accelerator Program is now accepting applications for its three-month hybrid program in Basel, Switzerland, targeting early-stage healthtech and techbio ventures. This equity-free opportunity offers financial support and potential follow-on funding.
University of Miami Announces Initiative for U.S. Phage Therapy Research
The University of Miami has announced a new research initiative dedicated to advancing U.S. phage therapy applications, a promising field for combating antibiotic-resistant bacteria. This strategic move positions the university as a key player in accelerating phage candidates from the lab to clinical settings.
The AI Personalization Engine: Driving Revenue and Reshaping Consumer Markets
With 77% of e-commerce professionals using AI daily, AI-powered personalization is no longer a future concept but a present-day engine of growth, driving up to 40% higher revenue and reshaping global consumer markets.
Gulf Funds Reportedly Near Deal to Back Paramount's Warner Bros Takeover
Paramount Skydance is reportedly lining up nearly $24 billion from Gulf sovereign funds to help finance its takeover of Warner Bros. Discovery, with Saudi Arabia’s Public Investment Fund expected to contribute roughly $10 billion.
The Nvidia Shift: From Hardware to Enterprise AI Solutions
Nvidia is undergoing a profound transformation, shifting its focus from being a premier GPU hardware provider to an architect of enterprise AI solutions. The launch of its open-source Agent Toolkit at GTC 2026 signals this strategic repositioning.
China's Cryopreservation Media Market: Analyzing Growth Drivers Through 2035
The foundational components of China's bio-preservation infrastructure are signaling a decade of sustained expansion, creating new strategic imperatives for companies in the life sciences sector.
Germany Seasonal Influenza Vaccines Market Defined by Policy and Production Cycles
Germany's seasonal influenza vaccine market is characterized by a dual-track procurement system, a time-compressed annual production cycle, and significant regulatory oversight. These elements create unique operational challenges and market dynamics.
Global Retinal Drugs Biologics Market Forecast to 2035 Shows Growth
The global retinal drugs and biologics market is projected for significant growth through 2035, primarily driven by aging populations and the increasing prevalence of diabetes. This expansion is also fueled by ongoing therapeutic innovation, including next-generation treatments for conditions like nAMD, DME, and geographic atrophy.
Beyond the Mainstream: The Data Behind Niche Market Specialization's Global Rise
The growth and impact of niche market specialization is reshaping global industries. From a microcar market projected to exceed $25 billion to hyper-focused technology platforms, data reveals a strategic shift away from mass markets and toward the significant opportunities within micro-segments.